Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/2012
05/08/2012US8173107 Delivery of antipsychotics through an inhalation route
05/08/2012CA2507027C Isoquinoline compounds and medicinal use thereof
05/08/2012CA2495827C 2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
05/08/2012CA2478655C Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
05/08/2012CA2459224C 1,3-benzothiazinone derivatives and the use thereof
05/08/2012CA2377661C Use of fatty acid derivative for the treatment of external secretion disorders
05/08/2012CA2368184C Method and means for treating post-polio syndrome
05/08/2012CA2353574C Analogues of glp-1
05/08/2012CA2340593C Use of vegf-c or vegf-d gene or protein to prevent restenosis
05/08/2012CA2229741C Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
05/08/2012CA2163211C Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
05/03/2012WO2012057635A1 Pine extract containing proanthocyanidins for treatment of traumatic brain injury
05/03/2012WO2012057291A1 Process for production of phenolic polymerizable compound having physiological activity
05/03/2012WO2012057288A1 Novel anti-dr5 antibody
05/03/2012WO2012057262A1 Pyridine derivative and medicinal agent
05/03/2012WO2012057248A1 Naphthyridine derivative
05/03/2012WO2012057247A1 Fused aminodihydropyrimidine derivative
05/03/2012WO2012057123A1 Collagen production promoter, hyaluronan production promoter, fibroblast proliferation promoter, and anti-wrinkle agent
05/03/2012WO2012056976A1 Modulator of activity of adenylate cyclase
05/03/2012WO2012056141A2 Method for producing articles of plant origin impregnated with a liquid plant substance
05/03/2012WO2012056120A1 Use of a modulator of the patched protein for regulating intracellular cholesterol concentration
05/03/2012WO2012055826A1 TREATMENT OF MeCP2-ASSOCIATED DISORDERS
05/03/2012US20120108680 Long-chain glycyl polyol type gelator and gel
05/03/2012US20120108648 Mitochondrial function-improving agent
05/03/2012US20120108634 Farnesyl protein transferase inhibitor combinations with antiestrogen agents
05/03/2012US20120108628 Inhibitors of protein tyrosine kinase activity
05/03/2012US20120108603 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
05/03/2012US20120108573 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
05/03/2012US20120108548 Molecular tweezers for the treatment of amyloid-related diseases
05/03/2012US20120108517 Agents and methods for denervation
05/03/2012US20120107897 Double-stranded oligonucleotides
05/03/2012US20120107833 Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof
05/03/2012US20120107827 PSMCs As Modifiers of the RB Pathway and Methods of Use
05/03/2012US20120107425 Use of rhodiola crenulata extract via the topical route
05/03/2012US20120107419 Oral rinse formulation and method of use
05/03/2012US20120107417 Effective Antitumor Treatments
05/03/2012US20120107393 Pellets for Delivery of Biologically Active Substances
05/03/2012US20120107389 Amphoteric liposomal compositions for cellular delivery of small rna molecules for use in rna interference
05/03/2012US20120107374 Coenzyme q10-containing composition
05/03/2012US20120107321 Antibodies And Epitopes Specific To Misfolded Prion Protein
05/03/2012US20120107286 Pluripotent stem cells
05/03/2012US20120107285 Mitochondrial enhancement of cells
05/03/2012US20120107236 Liver- receptor imaging injection, dispensing method and pharmaceutical composition thereof
05/03/2012CA2816291A1 Novel anti-dr5 antibody
05/03/2012CA2816285A1 Naphthyridine derivative
05/03/2012CA2815582A1 Treatment of mecp2-associated disorders
05/03/2012CA2815170A1 Pyridine derivative and medicinal agent
05/03/2012CA2814816A1 Method for producing articles of plant origin impregnated with a liquid plant substance
05/02/2012EP2447265A1 Novel thiophene carboxamide derivative and medicinal use of same
05/02/2012EP2447264A1 N-substituted-cyclic amino derivative
05/02/2012EP2447257A1 Drug for inhibiting lectin-like oxidized ldl receptor and drug for preventing arteriosclerosis
05/02/2012EP2447254A1 Crystals
05/02/2012EP2445490A2 Methods for treating or preventing fatigue
05/02/2012EP1992361B1 Remedy or preventive for digestive ulcer
05/02/2012EP1860114B1 Nitroguanosine-3 ,5 -cyclic monophosphate and protein kinase g activator
05/02/2012EP1724262B1 1-(2h)-isoquinolone derivative
05/02/2012EP1716851B1 Thioamides and salts thereof and cytokine production inhibitors containing both
05/02/2012EP1647546B1 Novel heteroaryl derivative
05/02/2012EP1634951B1 Novel protein
05/02/2012EP1627869B1 Vanilloid receptor modulators
05/02/2012EP1534668B1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
05/02/2012EP1517905B1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases
05/02/2012EP1429723B1 Treating effects of excessive reactive oxygen species
05/02/2012EP1418893B1 Compositions and techniques for localized therapy of restenosis
05/02/2012EP1343822B1 Means for the diagnosis and therapy of ctcl
05/02/2012EP1032403B1 Nutritional supplement for cerebral metabolic insufficiencies
05/02/2012CN102439007A Amide derivative
05/02/2012CN102438991A Carbinol compound having heterocyclic linker
05/02/2012CN102438641A Elastase inhibitor
05/02/2012CN102438623A Solid preparation containing npy y5 receptor antagonist
05/02/2012CN102438617A Matrix-type sustained release preparation containing basic additive
05/02/2012CN102430046A Aquatic product alive-keeping agent and preparation method and application thereof
05/02/2012CN102429996A Traditional Chinese medicine for treating salivation
05/02/2012CN102429908A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
05/02/2012CN102429907A Agent for overcoming resistance to anti-cancer agent
05/02/2012CN102008642B Traditional Chinese medicine for treating lupus erythematosus and inhibiting glucocorticoid side effect and application of traditional Chinese medicine
05/02/2012CN101190251B Rhodiola rosea chewable tablets and preparation method and application thereof
05/01/2012US8168827 Amide derivative
05/01/2012US8168637 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of diabetes
05/01/2012US8168616 Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
05/01/2012US8168592 CGRP peptide antagonists and conjugates
05/01/2012US8168587 Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases
05/01/2012US8168175 Pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger
05/01/2012CA2517888C Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
05/01/2012CA2493789C Anthranyl derivatives having an anti cholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof
05/01/2012CA2485217C Insulin-associated peptides with effects on cerebral health
05/01/2012CA2468583C Self-assembling multimeric binding complexes derived from ab5 toxin family members
05/01/2012CA2439604C N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
05/01/2012CA2438425C A novel proteosome-liposaccharide vaccine adjuvant
05/01/2012CA2437579C Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
05/01/2012CA2379858C Beta-amyloid peptide inhibitors
05/01/2012CA2333466C Gbs toxin receptor
04/2012
04/26/2012WO2012053606A1 Arylaminoheterocyclic carboxamide compound
04/26/2012WO2012053186A1 Arylamide derivatives as ttx-s blockers
04/26/2012US20120101161 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
04/26/2012US20120101155 Zinc Salt Compositions for the Prevention of Dermal and Mucosal Irritation
04/26/2012US20120101148 lipid formulation
04/26/2012US20120101143 Compounds Having Activity in Increasing Ion Transport by Mutant-CFTR and Uses Thereof
04/26/2012US20120101095 Alkoxy-thienopyrimidines as tgf-beta receptor kinase modulators
04/26/2012US20120101035 VEGF Antagonist Formulations
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 1564